XIENCE Nano

everolimus-eluting coronary stent · Abbott Medical Devices

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XIENCE Nano, covering 2014-11-25 to 2014-11-25. Get the full timeline:

Most recent: Clinical Trial Update: EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Eluting Coronary Stent Coronary Stents, Performance, and Technique in Chronic Total Occlusions [NA]

See pricing